期刊文献+

获得性血栓性血小板减少性紫癜免疫治疗的进展 被引量:2

下载PDF
导出
作者 王学文
出处 《中国微循环》 北大核心 2007年第3期209-212,共4页 Journal of Chinese Microcirculation
  • 相关文献

参考文献20

  • 1George JN.Thrombotic thrombocytopenic purpura[J].N Engl J Med2006,354(18):1927 ~ 1935
  • 2Elliott MA,Nichols WL.Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome[J].Mayo Clin Proc,2001,76(11):1154~1162
  • 3藤村吉博.TTP/HUSとVWF/ADAMTS-13.臨床血液,2003,44(12):1144-1153.
  • 4松本雅则 八木秀男 藤村吉博.VWF-cleaning protease/ADAMTS-13.臨床血液,2003,44(3):159-167.
  • 5Sadler JE,Moake JL,Miyata T,et al.Recent advances in thrombotic thormbocytopenic purpura[A].In:Am Soc Hemat Education Program Book[M].Orlando.Florida,2004,407 ~423
  • 6Veyradier A,Obert B,Houllieu A,et al.Specific vonWillebrand factor-cleaving protease in thrombotic microangiopathies:a study of 111cases[J].Blood,2001,98(6):1765 ~ 1772
  • 7Cataland SR,Wu HM.Immunotherapy for thrombotic thrombocytopenic purpura[J].Cur Opin Hematol,2005,12(2):359 ~363
  • 8Veyradier A,Obert B,Houllieu A,et al.Specific vonWillebrand factor-cleaving protease in thrombotic microangiopathies:a study of111cases[J].Blood,2001,98(6):1765 ~ 1772
  • 9Vesely SK,George JN,Lammle B,et al.ADAMTS-13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:related to presenting features and clinical outcomes in a prospective cohort of 142 patients[J].Blood,2003,102(1):60 ~68
  • 10Kremer Hovinga JA,Studt JD,Alberio L,et al.vonWillebrand factor-Cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies:The Swiss experience[J].Semin Hematol,2004,41 (1):75 ~ 82

共引文献8

同被引文献11

  • 1Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting as t - hrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient[ J]. Semin Thromb Hemost, 1999,25 ( 2 ) :217.
  • 2Swisher KK, Tcrrell DR, Vesely SK, et al. Clinical outcomes afterplate- let transfusions in patients with thrombotic thrombocytopenic purpura [J]. Transfusion,2009,49 ( 5 ) : 873.
  • 3Toumeh A,Josh N,Narwal R,et al.Refractory thrombotic thrombocytopenic purpura associated with primary Sjgren′s syndrome treated with Rituximab:a case report[J].Am J Ther,2014,21(2):e56-e60.
  • 4Schattner A,Friedman J,Klepfish A,et al.Thrombotic thrombocytopenic purpura as an initial presentation of primary Sjgren′s syndrome[J].Clin Rheumatol,2002,21(1):57-59.
  • 5Abe H,Tsuboi N,Yukawa S,et al.Thrombotic thrombocytopenic purpura complicating Sjgren′s syndrome with crescentic glomerulonephritis and membranous nephritis[J].Mod Rheumatol,2004,14(2):174-178.
  • 6Koga T,Yamasaki S,Nakamura H,et al.Renal thrombotic microangiopathies/thrombotic thrombocytopenic purpura in a patient with primary Sjgren′s syndrome complicated with IgM monoclonal gammopathy of undetermined significance[J].Rheumatol Int,2013,33(1):227-230.
  • 7Lin TY,Chang CC,Chang CC,et al.Cyclophosphamiderescued plasmapheresis-unresponsive secondary thrombotic thrombocytopenic purpura caused by Sjgren′s syndrome[J].Arch Med Sci,2012,8(5):934-938.
  • 8Yamashita H,Takahashi Y,Kaneko H,et al.Thrombotic thrombocytopenic purpura with an autoantibody to ADAMTS13complicating Sjgren′s syndrome:two cases and a literature review[J].Mod Rheumatol,2013,23(2):365-373.
  • 9Hovinga JA,Vesely SK,Terrell DR,et al.Survival and relapse in patients with thrombotic thrombocytopenic purpura[J].Blood,2010,115(8):1500-1511.
  • 10Jasti S,Coyle T,Gentile T,et al.Rituximab as an adjunct to plasma exchange in TTP:a report of 12cases and review of literature[J].J Clin Apher,2008,23(5):151-156.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部